OpenVSafe by OpenVAERS
Search V-safe

B4K-33580-67028

2 vaccinations 2 coded responses 5 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
787 / TX
Registered
2021-03-17
Relationship
Self
Race
Multiracial
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-16
    Dose 1 — Moderna
  2. 2021-03-17
    Registered in v-safe
  3. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-03-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-04-27
    Survey response — day 42, dose 1
    MedDRA: Pityriasis rosea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Gestational Pityriasis rosea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-27
    Report sent to call center — day 42, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-04-28
    Dose 2 — Moderna
  8. 2021-05-25
    Survey response — day 21, dose 2
    MedDRA: Office visit, Pityriasis rosea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: I discovered a rash that began to form about one week after first dose which was exacerbated by the second dose. Pityriasis Rocea · Healthcare visit (other): Dermatologist
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-25
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-05-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-06-02

Vaccinations

DoseDateManufacturerCo-administered
12021-03-16Moderna
22021-04-28Moderna

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 8 — day 42, dose 1

2021-04-27

Symptoms: Gestational Pityriasis rosea

Release 8 — day 21, dose 2

2021-05-25

Symptoms: I discovered a rash that began to form about one week after first dose which was exacerbated by the second dose. Pityriasis Rocea
Healthcare visit (other): Dermatologist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDPityriasis rosea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release